跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELONOX HP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ELONOX HP
Authorized
STANDARD
ELONOX HP
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
71eaab8944a2b486
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
71eaab8944a2b486
Drug Approval Canada Name
ELONOX HP
Product Name
ELONOX HP
Status
Marketed
Status Date
2023-03-09
Original Market Date
2023-03-09
Din
02532301
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intravenous
Schedule
Prescription
Ahfs
20:12.04.16
Atc Original
B01AB05 ENOXAPARIN
Atc Name
b 01 ab 05
Aig Number
0131860002
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
ENOXAPARIN SODIUM
120 MG / 0.8 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
71eaab8944a2b486
Type
Standard
Back to Health Canada Approvals